Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement

Journal of Cosmetic Dermatology

Volumn 9, Issue 2, 2010, Pages 96-102

  Woodward, Julie A ^a   Haggerty, Chris J ^a   Stinnett, Sandra S ^a   Williams, Zinaria Y ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bimatoprost; Eyelash growth; Prostaglandins

Indexed keywords

ANTIBIOTIC AGENT; BIMATOPROST; PREDNISOLONE ACETATE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; EPIPHORA; EYE REDNESS; EYE TENDERNESS; EYELASH; EYELID BUMP; EYELID DISEASE; EYELID HYPEREMIA; FEMALE; GEL; HAIR GROWTH; HUMAN; HUMAN EXPERIMENT; HYPERPIGMENTATION; HYPERTRICHOSIS; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; PHOTOPHOBIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; TREATMENT FAILURE; VISUAL ACUITY;

ADULT; AGED; AMIDES; CLOPROSTENOL; DOUBLE-BLIND METHOD; EYELASHES; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 77954445858     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2010.00487.x     Document Type: Article

References (16)

1. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997, 124:544-7.
2. Johnstone MA, Albert DM. Prostaglandin-induced hair growth. Surv Ophthalmol 2002, 47(Suppl. 1):S185-202.
3. Parentin F. Granulomatous anterior uveitis associated with bimatoprost: a case report. Ocul Immunol Inflamm 2003, 11:67-71.
4. Higginbotham EJ, Schuman JS, Goldberg I. One-year randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol 2002, 120:1286-93.
5. Sherwood M, Brandt J. Six month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol 2001, 45(Suppl. 4):S361-8.
6. Ayyala RS, Cruz DA, Margo CE. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes. Am J Ophthalmol 1998, 126:602-4.
7. Galloway GD, Eke T, Broadway DC. Periocular cutaneous pigmentary changes associated with bimatoprost use. Arch Ophthalmol 2005, 123:1541-6.
8. Kroll DM, Schuman JS. Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol 2002, 133:401-3.
9. Drug That Lengthens Eyelashes Sets Off Flutter http://online.wsj.com/article/SB119543055372597359.html?mod=googlenews_wsj, Available at , accessed 21 November 2009
10. Brandt JD, VanDenburgh AM, Chen K, Whitcup SM. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology 2001, 108:1023-31.
11. Noecker RS, Dirks MS, Choplin NT. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 2003, 135:55-63.
12. Division of Anti-Infective and Ophthalmology Products Advisory Committee Meeting Briefing Package for Bimatoprost Ophthalmic Solution for the Treatment of Hypotrichosis of the Eyelashes http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4397b1-03-FDA.pdf, Available at: , assessed 21 November 2009
13. Packer M, Fine IH, Hoffman RS. Bilateral nongranulomatous anterior uveitis associated with bimatoprost. J Cataract Refract Surg 2003, 29:2242-3.
14. Cohen JS, Gross RL, Cheetham JK. Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. Surv Ophthalmol 2004, 49(Suppl. 1):S45-52.
15. Approximately $2 Million of Potentially Harmful " Cosmetic" Eye Product Seized http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109028.htm, Available at: , accessed 21 November 2009
16. Sugimoto M, Sugimoto M, Uji Y. Quantitative analysis of eyelash lengthening following topical latanoprost therapy. Can J Ophthalmol 2002, 37:342-5.